{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:34:59Z","timestamp":1790764499244,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_FULL_2020_01"],"award-info":[{"award-number":["IIG_FULL_2020_01"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer Research UK 25","award":["C18281\/A29019 programme grant (the Integrative Cancer Epidemiology Programme)"],"award-info":[{"award-number":["C18281\/A29019 programme grant (the Integrative Cancer Epidemiology Programme)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10552-023-01712-z","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T11:45:40Z","timestamp":1684151140000},"page":"725-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Blood pressure, calcium channel blockers, and the risk of prostate cancer: a Mendelian randomization study"],"prefix":"10.1007","volume":"34","author":[{"given":"Nabila","family":"Kazmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Valeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulshat R.","family":"Khasanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Plotnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PRACTICAL Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"issue":"3","key":"1712_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1712_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jjco\/hyl049","volume":"36","author":"T Marugame","year":"2006","unstructured":"Marugame T, Katanoda K (2006) International comparisons of cumulative risk of breast and prostate cancer, from cancer incidence in five continents Vol. VIII. Jpn J Clin Oncol 36(6):399\u2013400. https:\/\/doi.org\/10.1093\/jjco\/hyl049","journal-title":"Jpn J Clin Oncol"},{"issue":"S10","key":"1712_CR3","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/cncr.20408","volume":"101","author":"DG Bostwick","year":"2004","unstructured":"Bostwick DG, Burke HB, Djakiew D et al (2004) Human prostate cancer risk factors. Cancer 101(S10):2371\u20132490. https:\/\/doi.org\/10.1002\/cncr.20408","journal-title":"Cancer"},{"issue":"6","key":"1712_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00345-017-2038-0","volume":"35","author":"MR Cooperberg","year":"2017","unstructured":"Cooperberg MR, Chan JM (2017) Epidemiology of prostate cancer. World J Urol 35(6):849\u2013849. https:\/\/doi.org\/10.1007\/s00345-017-2038-0","journal-title":"World J Urol"},{"issue":"2","key":"1712_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3909\/riu0758","volume":"19","author":"S Navin","year":"2017","unstructured":"Navin S, Ioffe V (2017) The association between hypertension and prostate cancer. Rev Urol 19(2):113\u2013118. https:\/\/doi.org\/10.3909\/riu0758","journal-title":"Rev Urol"},{"issue":"7","key":"1712_CR6","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ijc.25171","volume":"127","author":"T Stocks","year":"2010","unstructured":"Stocks T, Hergens MP, Englund A, Ye W, Stattin P (2010) Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer 127(7):1660\u20131668. https:\/\/doi.org\/10.1002\/ijc.25171","journal-title":"Int J Cancer"},{"issue":"6","key":"1712_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1590\/1677-553820133806769","volume":"38","author":"FR Romero","year":"2012","unstructured":"Romero FR, Romero AW, de Almeida RMS, Oliveira FC Jr, Tambara Filho R (2012) The significance of biological, environmental, and social risk factors for prostate cancer in a cohort study in Brazil. Int Braz J Urol 38(6):769\u2013778. https:\/\/doi.org\/10.1590\/1677-553820133806769","journal-title":"Int Braz J Urol"},{"issue":"5","key":"1712_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/cncr.22461","volume":"109","author":"JL Beebe-Dimmer","year":"2007","unstructured":"Beebe-Dimmer JL, Dunn RL, Sarma AV, Montie JE, Cooney KA (2007) Features of the metabolic syndrome and prostate cancer in African-American men. Cancer 109(5):875\u2013881. https:\/\/doi.org\/10.1002\/cncr.22461","journal-title":"Cancer"},{"issue":"11","key":"1712_CR9","first-page":"863","volume":"6","author":"H Tulinius","year":"1997","unstructured":"Tulinius H, Sigf\u00fasson N, Sigvaldason H, Bjarnad\u00f3ttir K, Tryggvadottir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Prev Biomark 6(11):863\u2013873","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"6","key":"1712_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/j.1464-410X.2010.09703.x","volume":"107","author":"LP Wallner","year":"2011","unstructured":"Wallner LP, Morgenstern H, McGree ME et al (2011) The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study: METABOLIC CONDITIONS AND PROSTATE CANCER INCIDENCE. BJU Int 107(6):929\u2013935. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09703.x","journal-title":"BJU Int"},{"issue":"1","key":"1712_CR11","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1186\/s12885-021-09067-x","volume":"21","author":"II Chan","year":"2021","unstructured":"Chan II, Kwok MK, Schooling CM (2021) Blood pressure and risk of cancer: a Mendelian randomization study. BMC Cancer 21(1):1338. https:\/\/doi.org\/10.1186\/s12885-021-09067-x","journal-title":"BMC Cancer"},{"issue":"1","key":"1712_CR12","doi-asserted-by":"publisher","first-page":"31358","DOI":"10.1038\/srep31358","volume":"6","author":"Z Liang","year":"2016","unstructured":"Liang Z, Xie B, Li J et al (2016) Hypertension and risk of prostate cancer: a systematic review and meta-analysis. Sci Rep 6(1):31358. https:\/\/doi.org\/10.1038\/srep31358","journal-title":"Sci Rep"},{"issue":"1","key":"1712_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/s19010139","volume":"19","author":"M Cabello","year":"2019","unstructured":"Cabello M, Ge H, Aracil C et al (2019) Extracellular electrophysiology in the prostate cancer cell model PC-3. Sensors 19(1):139. https:\/\/doi.org\/10.3390\/s19010139","journal-title":"Sensors"},{"issue":"1","key":"1712_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1515\/bmc-2022-0012","volume":"13","author":"C Marchetti","year":"2022","unstructured":"Marchetti C (2022) Calcium signaling in prostate cancer cells of increasing malignancy. Biomol Concepts 13(1):156\u2013163. https:\/\/doi.org\/10.1515\/bmc-2022-0012","journal-title":"Biomol Concepts"},{"issue":"1","key":"1712_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/1574892811308010018","volume":"8","author":"G Shapovalov","year":"2012","unstructured":"Shapovalov G, Skryma R, Prevarskaya N (2012) Calcium channels and prostate cancer. Recent Patents Anticancer Drug Discov 8(1):18\u201326. https:\/\/doi.org\/10.2174\/1574892811308010018","journal-title":"Recent Patents Anticancer Drug Discov"},{"issue":"9026","key":"1712_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(96)04277-8","volume":"348","author":"M Pahor","year":"1996","unstructured":"Pahor M, Guralnik JM, Ferrucci L et al (1996) Calcium-channel blockade and incidence of cancer in aged populations. Lancet 348(9026):493\u2013497. https:\/\/doi.org\/10.1016\/S0140-6736(96)04277-8","journal-title":"Lancet"},{"issue":"10","key":"1712_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s10552-011-9819-3","volume":"22","author":"KJ Kemppainen","year":"2011","unstructured":"Kemppainen KJ, Tammela TLJ, Auvinen A, Murtola TJ (2011) The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case\u2013control study. Cancer Causes Control 22(10):1445\u20131452. https:\/\/doi.org\/10.1007\/s10552-011-9819-3","journal-title":"Cancer Causes Control"},{"issue":"12","key":"1712_CR18","doi-asserted-by":"publisher","first-page":"e50893","DOI":"10.1371\/journal.pone.0050893","volume":"7","author":"L Azoulay","year":"2012","unstructured":"Azoulay L, Assimes TL, Yin H, Bartels DB, Schiffrin EL, Suissa S (2012) Long-term use of angiotensin receptor blockers and the risk of cancer. PLoS ONE 7(12):e50893. https:\/\/doi.org\/10.1371\/journal.pone.0050893","journal-title":"PLoS ONE"},{"issue":"1","key":"1712_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12894-018-0318-7","volume":"18","author":"L Cao","year":"2018","unstructured":"Cao L, Zhang S, Jia C-M et al (2018) Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies. BMC Urol 18(1):17. https:\/\/doi.org\/10.1186\/s12894-018-0318-7","journal-title":"BMC Urol"},{"issue":"9","key":"1712_CR20","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.clinthera.2020.06.021","volume":"42","author":"H Yang","year":"2020","unstructured":"Yang H, Yu Y, Hu X et al (2020) Association between the overall risk of prostate cancer and use of calcium channel blockers: a systematic review and meta-analysis. Clin Ther 42(9):1715-1727.e2. https:\/\/doi.org\/10.1016\/j.clinthera.2020.06.021","journal-title":"Clin Ther"},{"issue":"4","key":"1712_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/jcpt.12673","volume":"43","author":"AA Thakur","year":"2018","unstructured":"Thakur AA, Wang X, Garcia-Betancourt MM, Forse RA (2018) Calcium channel blockers and the incidence of breast and prostate cancer: a meta-analysis. J Clin Pharm Ther 43(4):519\u2013529. https:\/\/doi.org\/10.1111\/jcpt.12673","journal-title":"J Clin Pharm Ther"},{"issue":"8","key":"1712_CR22","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1371\/journal.pmed.0050177","volume":"5","author":"NA Sheehan","year":"2008","unstructured":"Sheehan NA, Didelez V, Burton PR, Tobin MD (2008) Mendelian randomisation and causal inference in observational epidemiology. PLoS Med 5(8):e177. https:\/\/doi.org\/10.1371\/journal.pmed.0050177","journal-title":"PLoS Med"},{"issue":"1","key":"1712_CR23","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt AF, Finan C, Gordillo-Mara\u00f1\u00f3n M et al (2020) Genetic drug target validation using Mendelian randomisation. Nat Commun 11(1):3255. https:\/\/doi.org\/10.1038\/s41467-020-16969-0","journal-title":"Nat Commun"},{"issue":"4","key":"1712_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41591-021-01310-z","volume":"27","author":"L Gaziano","year":"2021","unstructured":"Gaziano L, Giambartolomei C, Pereira AC et al (2021) Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19. Nat Med 27(4):668\u2013676. https:\/\/doi.org\/10.1038\/s41591-021-01310-z","journal-title":"Nat Med"},{"key":"1712_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2233","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR et al (2021) Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. https:\/\/doi.org\/10.1136\/bmj.n2233","journal-title":"BMJ"},{"issue":"7726","key":"1712_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D et al (2018) The UK Biobank resource with deep phenotyping and genomic data. Nature 562(7726):203\u2013209. https:\/\/doi.org\/10.1038\/s41586-018-0579-z","journal-title":"Nature"},{"issue":"3","key":"1712_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/ng.3768","volume":"49","author":"HR Warren","year":"2017","unstructured":"Warren HR, Evangelou E, Cabrera CP et al (2017) Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet 49(3):403\u2013415. https:\/\/doi.org\/10.1038\/ng.3768","journal-title":"Nat Genet"},{"issue":"7","key":"1712_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher FR, Al Olama AA, Berndt SI et al (2018) Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet 50(7):928\u2013936. https:\/\/doi.org\/10.1038\/s41588-018-0142-8","journal-title":"Nat Genet"},{"issue":"7422","key":"1712_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"The 1000 Genomes Project Consortium","year":"2012","unstructured":"The 1000 Genomes Project Consortium (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491(7422):56\u201365. https:\/\/doi.org\/10.1038\/nature11632","journal-title":"Nature"},{"issue":"10","key":"1712_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/ng.3094","volume":"46","author":"AA Al Olama","year":"2014","unstructured":"Al Olama AA, Kote-Jarai Z, Berndt SI et al (2014) A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet 46(10):1103\u20131109. https:\/\/doi.org\/10.1038\/ng.3094","journal-title":"Nat Genet"},{"issue":"6","key":"1712_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1534\/g3.111.001198","volume":"1","author":"B Howie","year":"2011","unstructured":"Howie B, Marchini J, Stephens M (2011) Genotype imputation with thousands of genomes. G3 Genes Genomes Genet 1(6):457\u2013470. https:\/\/doi.org\/10.1534\/g3.111.001198","journal-title":"G3 Genes Genomes Genet"},{"issue":"4","key":"1712_CR32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","volume":"50","author":"R Malik","year":"2018","unstructured":"Malik R, Chauhan G, Traylor M et al (2018) Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet 50(4):524\u2013537. https:\/\/doi.org\/10.1038\/s41588-018-0058-3","journal-title":"Nat Genet"},{"issue":"4","key":"1712_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng.784","volume":"43","author":"H Schunkert","year":"2011","unstructured":"Schunkert H, K\u00f6nig IR, Kathiresan S et al (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43(4):333\u2013338. https:\/\/doi.org\/10.1038\/ng.784","journal-title":"Nat Genet"},{"issue":"2","key":"1712_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/HJH.0b013e3282f25b5a","volume":"26","author":"B Gavish","year":"2008","unstructured":"Gavish B, Ben-Dov IZ, Bursztyn M (2008) Linear relationship between systolic and diastolic blood pressure monitored over 24 h: assessment and correlates. J Hypertens 26(2):199\u2013209. https:\/\/doi.org\/10.1097\/HJH.0b013e3282f25b5a","journal-title":"J Hypertens"},{"issue":"3","key":"1712_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/HJH.0b013e32801449fb","volume":"25","author":"MJE van Rijn","year":"2007","unstructured":"van Rijn MJE, Schut AF, Aulchenko YS et al (2007) Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related genes. J Hypertens 25(3):565\u2013570. https:\/\/doi.org\/10.1097\/HJH.0b013e32801449fb","journal-title":"J Hypertens"},{"issue":"10","key":"1712_CR36","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","volume":"50","author":"E Evangelou","year":"2018","unstructured":"Evangelou E, Warren HR, Mosen-Ansorena D et al (2018) Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet 50(10):1412\u20131425. https:\/\/doi.org\/10.1038\/s41588-018-0205-x","journal-title":"Nat Genet"},{"issue":"D1","key":"1712_CR37","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC et al (2018) DrugBank 50: a major update to the DrugBank database for 2018. Nucleic Acids Res 46(D1):D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Res"},{"key":"1712_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.5","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I et al (2016) The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform. https:\/\/doi.org\/10.1002\/cpbi.5","journal-title":"Curr Protoc Bioinform"},{"issue":"4","key":"1712_CR39","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1212\/WNL.0000000000009814","volume":"95","author":"MK Georgakis","year":"2020","unstructured":"Georgakis MK, Gill D, Webb AJS et al (2020) Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes. Neurology 95(4):e353\u2013e361. https:\/\/doi.org\/10.1212\/WNL.0000000000009814","journal-title":"Neurology"},{"key":"1712_CR40","doi-asserted-by":"publisher","DOI":"10.48550\/ARXIV.2101.04081","author":"A Gkatzionis","year":"2021","unstructured":"Gkatzionis A, Burgess S, Newcombe PJ (2021) Statistical methods for cis-Mendelian randomization. Genet Epidemiol. https:\/\/doi.org\/10.48550\/ARXIV.2101.04081","journal-title":"Genet Epidemiol"},{"issue":"7","key":"1712_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"EPIC- InterAct Consortium, Burgess S, Scott RA, Timpson NJ, Davey-Smith G, Thompson SG (2015) Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol 30(7):543\u2013552. https:\/\/doi.org\/10.1007\/s10654-015-0011-z","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"1712_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965","journal-title":"Genet Epidemiol"},{"issue":"6","key":"1712_CR43","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J (2017) Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol 46(6):1985\u20131998. https:\/\/doi.org\/10.1093\/ije\/dyx102","journal-title":"Int J Epidemiol"},{"issue":"2","key":"1712_CR44","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1712_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7","journal-title":"Nat Genet"},{"issue":"5","key":"1712_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32(5):377\u2013389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x","journal-title":"Eur J Epidemiol"},{"issue":"20","key":"1712_CR47","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","volume":"27","author":"L Yengo","year":"2018","unstructured":"Yengo L, Sidorenko J, Kemper KE et al (2018) Meta-analysis of genome-wide association studies for height and body mass index in \u223c700000 individuals of European ancestry. Hum Mol Genet 27(20):3641\u20133649. https:\/\/doi.org\/10.1093\/hmg\/ddy271","journal-title":"Hum Mol Genet"},{"issue":"22","key":"1712_CR48","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R et al (2019) PhenoScanner V2: an expanded tool for searching human genotype\u2013phenotype associations. Bioinformatics 35(22):4851\u20134853. https:\/\/doi.org\/10.1093\/bioinformatics\/btz469","journal-title":"Bioinformatics"},{"issue":"2","key":"1712_CR49","first-page":"73","volume":"6","author":"SJ Freedland","year":"2004","unstructured":"Freedland SJ, Aronson WJ (2004) Examining the relationship between obesity and prostate cancer. Rev Urol 6(2):73","journal-title":"Rev Urol"},{"issue":"12","key":"1712_CR50","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/hr.2017.75","volume":"40","author":"M Leggio","year":"2017","unstructured":"Leggio M, Lombardi M, Caldarone E et al (2017) The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res 40(12):947\u2013963. https:\/\/doi.org\/10.1038\/hr.2017.75","journal-title":"Hypertens Res"},{"issue":"2","key":"1712_CR51","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41433-021-01759-9","volume":"36","author":"MR Phillips","year":"2022","unstructured":"Phillips MR, Kaiser P, Thabane L et al (2022) Risk of bias: why measure it, and how? Eye 36(2):346\u2013348. https:\/\/doi.org\/10.1038\/s41433-021-01759-9","journal-title":"Eye"},{"issue":"12","key":"1712_CR52","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/ajh\/hpaa098","volume":"33","author":"E Sanidas","year":"2020","unstructured":"Sanidas E, Velliou M, Papadopoulos D et al (2020) Antihypertensive drugs and risk of cancer: between scylla and charybdis. Am J Hypertens 33(12):1049\u20131058. https:\/\/doi.org\/10.1093\/ajh\/hpaa098","journal-title":"Am J Hypertens"},{"issue":"2","key":"1712_CR53","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3892\/ol.2017.6457","volume":"14","author":"NN Phan","year":"2017","unstructured":"Phan NN, Wang CY, Chen CF, Sun Z, Lai MD, Lin YC (2017) Voltage-gated calcium channels: novel targets for cancer therapy. Oncol Lett 14(2):2059\u20132074. https:\/\/doi.org\/10.3892\/ol.2017.6457","journal-title":"Oncol Lett"},{"issue":"22","key":"1712_CR54","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1093\/emboj\/cdg583","volume":"22","author":"S Moosmang","year":"2003","unstructured":"Moosmang S, Schulla V, Welling A et al (2003) Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J 22(22):6027\u20136034. https:\/\/doi.org\/10.1093\/emboj\/cdg583","journal-title":"EMBO J"},{"issue":"1","key":"1712_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/35036035","volume":"1","author":"MJ Berridge","year":"2000","unstructured":"Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1(1):11\u201321. https:\/\/doi.org\/10.1038\/35036035","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"38","key":"1712_CR56","doi-asserted-by":"publisher","first-page":"31666","DOI":"10.1074\/jbc.R112.343061","volume":"287","author":"GR Monteith","year":"2012","unstructured":"Monteith GR, Davis FM, Roberts-Thomson SJ (2012) Calcium channels and pumps in cancer: changes and consequences. J Biol Chem 287(38):31666\u201331673. https:\/\/doi.org\/10.1074\/jbc.R112.343061","journal-title":"J Biol Chem"},{"issue":"5","key":"1712_CR57","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.urolonc.2013.08.001","volume":"32","author":"KR Loughlin","year":"2014","unstructured":"Loughlin KR (2014) Calcium channel blockers and prostate cancer. Urol Oncol Semin Orig Investig 32(5):537\u2013538. https:\/\/doi.org\/10.1016\/j.urolonc.2013.08.001","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"8","key":"1712_CR58","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey SG (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133\u20131163. https:\/\/doi.org\/10.1002\/sim.3034","journal-title":"Stat Med"},{"issue":"7549","key":"1712_CR59","doi-asserted-by":"publisher","first-page":"1080.1","DOI":"10.1136\/bmj.332.7549.1080","volume":"332","author":"DG Altman","year":"2006","unstructured":"Altman DG, Royston P (2006) The cost of dichotomising continuous variables. BMJ 332(7549):1080.1. https:\/\/doi.org\/10.1136\/bmj.332.7549.1080","journal-title":"BMJ"},{"issue":"1","key":"1712_CR60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/sim.2331","volume":"25","author":"P Royston","year":"2006","unstructured":"Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25(1):127\u2013141. https:\/\/doi.org\/10.1002\/sim.2331","journal-title":"Stat Med"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01712-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-023-01712-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01712-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:04:59Z","timestamp":1686787499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-023-01712-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1712"],"URL":"https:\/\/doi.org\/10.1007\/s10552-023-01712-z","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,13]]},"assertion":[{"value":"16 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All participants provided written or oral informed consent, and the studies included were reviewed and approved by their respective review boards or ethics committees.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}